Cargando…
Dose Schedule Optimization and the Pharmacokinetic Driver of Neutropenia
Toxicity often limits the utility of oncology drugs, and optimization of dose schedule represents one option for mitigation of this toxicity. Here we explore the schedule-dependency of neutropenia, a common dose-limiting toxicity. To this end, we analyze previously published mathematical models of n...
Autores principales: | Patel, Mayankbhai, Palani, Santhosh, Chakravarty, Arijit, Yang, Johnny, Shyu, Wen Chyi, Mettetal, Jerome T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215876/ https://www.ncbi.nlm.nih.gov/pubmed/25360756 http://dx.doi.org/10.1371/journal.pone.0109892 |
Ejemplares similares
-
Growth Rate Analysis and Efficient Experimental Design for Tumor Xenograft Studies
por: Hather, Gregory, et al.
Publicado: (2014) -
Systems Pharmacology Model of Gastrointestinal Damage Predicts Species Differences and Optimizes Clinical Dosing Schedules
por: Shankaran, Harish, et al.
Publicado: (2017) -
Difference in Neutropenia due to Administration Schedule of TAS-102
por: Yoshida, Yoichiro, et al.
Publicado: (2017) -
Quantitative Systems Pharmacology Modeling of Avadomide-Induced Neutropenia Enables Virtual Clinical Dose and Schedule Finding Studies
por: Abbiati, Roberto A., et al.
Publicado: (2021) -
Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone
por: Sood, Shabnam
Publicado: (2017)